Both in Pharmaceuticals
Talphera vs Oncolytics Biotech
Over the past year TLPH returned −16.9% and ONCY returned −63.3%; their daily moves had a correlation of 0.18.
TLPH −16.9% ONCY −63.3%Growth of $1, one year, split-adjusted
| Metric | TLPH | ONCY |
|---|---|---|
| Price | $1.03 | $0.4254 |
| Market cap | $53.5M | $55.8M |
| Today | −3.74% | −0.54% |
| 1 month | −8.0% | −33.7% |
| 6 months | +12.1% | −51.1% |
| Year to date | −9.6% | −51.3% |
| 1 year | −16.3% | −63.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 53,463.0× | — |
| Net cash | $17.1M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 42.8% | 63.7% |
| Short % of float | 4.1% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).